Artwork

Content provided by Simranjit Singh. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Simranjit Singh or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

STH - E21 Eric Wang

28:32
 
Share
 

Manage episode 182361289 series 1022739
Content provided by Simranjit Singh. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Simranjit Singh or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Eric Wang is a PhD candidate in the lab of Dr. Iannis Aifantis at the NYU School of Medicine. Broadly speaking, Eric's research focuses on transcriptional regulation during leukemia initiation. To this end, he recently conducted a pooled CRISPR screen on about 500 target genes, from which a gene involved in RNA splicing emerged as a top candidate as being required for leukemia cells to live. In addition to this screen, we discuss Eric's unique path to his current position and his recent PhD qualifying exam. For more information on Eric's and Dr. Aifantis' research, visit his lab page: Aifantis Lab

  continue reading

30 episodes

Artwork
iconShare
 
Manage episode 182361289 series 1022739
Content provided by Simranjit Singh. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Simranjit Singh or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Eric Wang is a PhD candidate in the lab of Dr. Iannis Aifantis at the NYU School of Medicine. Broadly speaking, Eric's research focuses on transcriptional regulation during leukemia initiation. To this end, he recently conducted a pooled CRISPR screen on about 500 target genes, from which a gene involved in RNA splicing emerged as a top candidate as being required for leukemia cells to live. In addition to this screen, we discuss Eric's unique path to his current position and his recent PhD qualifying exam. For more information on Eric's and Dr. Aifantis' research, visit his lab page: Aifantis Lab

  continue reading

30 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide